Article

In 2025, STEER World announced the successful global validation of its bioenergy and pharmaceutical technologies, supporting India's Compressed Biogas mission with plans for over 50 biogas plants by March 2026. The company also facilitated Bionpharma Inc.'s USFDA approval for generic Etravirine tablets using its FragMelt™ platform, while its Integraal™ Continuous Granulation System has been adopted for the commercial manufacture of seven drugs, underscoring India's advancements in deep-tech innovation across energy and healthcare sectors.